Oxygenta Pharmaceutical Q2 Results

  • BSE: 524636
  • NSE: -
  • ISIN: INE102E01018
  • Sector: Biotechnology & Drugs
BSE
74.81.70 (2.33%)
Volume16.27 K
Updated: Mon 25 Nov, 2024 | 15:29:21
NSE
This stock is not traded on NSE
Today: 73.21
76.68
52-Wk: 26.01
108.64

Q2 Results Highlights

  • Total Income
    ₹14.01 Cr.
    (10.97%)
  • Operating Profit
    ₹-1.45 Cr.
    (-1.06%)
  • Profit After Tax
    ₹-2.85 Cr.
    (109.34%)
  • Operating Margin
    -10.32%
    (-48.87%)
Note: Comparison is on YoY basis

Quarterly - Oxygenta Pharmaceutical Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 14.016.86-%13.08-%
Selling/ General/ Admin Expenses Total 1.400.18-%0.33-%
Depreciation/ Amortization 0.660.50-%0.83-%
Total Operating Expense 15.4510.77-%15.72-%
Operating Income -1.45-3.90-%-2.64-%
Net Income Before Taxes -2.77-4.56-%-3.18-%
Net Income -2.85-4.56-%-3.16-%
Diluted Normalized EPS -0.81-1.60-%-0.86-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts